Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.40%
#2 Pons Pons +33.09%
#3 TENDIES TENDIES +31.51%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.78%
#5 Starpower Starpower +28.97%
#6 StonkBroker StonkBroker +23.95%
#7 SkyAI SkyAI +22.66%
#8 Mubarak Mubarak +22.28%
#9 PondCoin PondCoin +21.09%
#10 Ocean Protocol Ocean Protocol +19.89%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
設定
言語
日本
通貨
USD
テーマ
Celularity Inc. Celularity Inc.

Celularity Inc.

CELU
株式のランク #28923
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to... Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing through Phase I trials for acute myeloid leukemia and Phase I/IIa trials for glioblastoma multiforme and COVID-19; and CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I for HER2+ gastric and gastroesophageal cancers. Furthermore, two mesenchymal-like adherent stromal cell candidates, APPL-001 and PDA-002 (both derived from placentas), are in pre-clinical development for Crohn's disease and facioscapulohumeral muscular dystrophy, respectively. In addition to its therapeutic development, Celularity is involved in commercial activities, offering surgical and wound care products like Biovance and Interfyl through sales and licensing agreements. The company also specializes in collecting stem cells from umbilical cords and placentas, providing storage services under its LifebankUSA brand. Founded in 2016, Celularity Inc. maintains its headquarters in Florham Park, New Jersey.
株価
$0.8353
時価総額
$24.18M
変化（1日）
13.38%
変化（1年）
-76.86%
国
US
取引 Celularity Inc. (CELU)

カテゴリー

Healthcare
Celularity Inc.（CELU）のEPS
2026 時点のEPS TTM: 0
Celularity Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Celularity Inc.のEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH